Association between Chronic Pain and Alterations in the Mesolimbic Dopaminergic System

Association between Chronic Pain and Alterations in the Mesolimbic Dopaminergic System

Chronic pain (pain lasting for >3 months) decreases patient quality of life and even occupational abilities. It can be controlled by treatment, but often persists even after management. To properly control pain, its underlying mechanisms must be determined. This review outlines the role of the me...

Full description

Bibliographic Details
Main Authors:	Seoyon Yang, Mathieu Boudier-Revéret, Yoo Jin Choo, Min Cheol Chang
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Brain Sciences
Subjects:	mesolimbic system dopaminergic system chronic pain dopaminergic drug depression addiction
Online Access:	https://www.mdpi.com/2076-3425/10/10/701

Similar Items

Elucidation of the mechanisms of exercise-induced hypoalgesia and pain prolongation due to physical stress and the restriction of movement
by: Kenichi Tanaka, et al.
Published: (2023-08-01)

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
by: Marjorie C. Gondré-Lewis, et al.
Published: (2022-04-01)

Dopaminergic Modulation of Prefrontal Cortex Inhibition
by: Danila Di Domenico, et al.
Published: (2023-04-01)

The effects of long-term dopaminergic treatment on locomotor behavior in rats
by: Welinton Alessandro Oliveira de Almeida, et al.
Published: (2014-12-01)

Dopaminergic deficiency syndrome in the picture of severe brain injury in the presence of protracted depression of consciousness
by: M. V. Chelyapina, et al.
Published: (2014-12-01)

A functional characterisation of retrorubral field dopaminergic neurons
by: Bryden, LA
Published: (2021)

Dopaminergic system and its relationship with the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-thyroid systems (review)
by: I. N. Molodovskaya
Published: (2020-12-01)

Is It Possible to Shift from Down to Top Rank? A Focus on the Mesolimbic Dopaminergic System and Cocaine Abuse
by: Inês M. Amaral, et al.
Published: (2021-07-01)

Morphine and microRNA activity: Is there a relation with addiction?
by: Raquel Emilia Rodriguez
Published: (2012-11-01)

Dopaminergic metabolism is affected by intracerebral injection of Tb II-I isolated from Tityus bahiensis scorpion venom
by: Beraldo-Neto Emidio, et al.
Published: (2022-09-01)

Hypocretin / Orexin Receptor 1 Knockdown in GABA or Dopamine Neurons in the Ventral Tegmental Area Differentially Impact Mesolimbic Dopamine and Motivation for Cocaine
by: Emily M. Black, et al.
Published: (2023-09-01)

The association of genetic polymorphisms within the dopaminergic system with nicotine dependence: A narrative review
by: Jingjing Yang, et al.
Published: (2024-06-01)

The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons
by: Walaa F. Alsanie, et al.
Published: (2022-03-01)

Neuroprotective Effects of Salidroside on Cerebral Ischemia/Reperfusion-Induced Behavioral Impairment Involves the Dopaminergic System
by: Zhi-feng Zhong, et al.
Published: (2019-12-01)

Dopaminergic System in Promoting Recovery from General Anesthesia
by: Jinxu Wang, et al.
Published: (2023-03-01)

Dopaminergic and non-dopaminergic mechanisms of non-motor symptoms of Parkinson disease
by: Titus Mihai Vasile, et al.
Published: (2012-12-01)

Evidence for direct dopaminergic connections between substantia nigra pars compacta and thalamus in young healthy humans
by: Giovanni Cirillo, et al.
Published: (2025-01-01)

The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension
by: Waleed N. Qaddumi, et al.
Published: (2021-02-01)

Latency to Reward Predicts Social Dominance in Rats: A Causal Role for the Dopaminergic Mesolimbic System
by: Laura Lozano-Montes, et al.
Published: (2019-04-01)

Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist
by: Anastasia P Athanasoulia-Kaspar, et al.
Published: (2018-02-01)

Batryticatus Bombyx Protects Dopaminergic Neurons Against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
by: Hye-Sun Lim, et al.
Published: (2019-11-01)

The mesolimbic system and the loss of higher order network features in schizophrenia when learning without reward
by: Elizabeth Martin, et al.
Published: (2024-09-01)

Dopaminergic dysregulation syndrome associated with Othello’s syndrome in a patient with Parkinson’s disease: about a clinical case
by: R. Masmoudi, et al.
Published: (2022-06-01)

High-Salt Diet Causes Sleep Fragmentation in Young Drosophila Through Circadian Rhythm and Dopaminergic Systems
by: Jiayu Xie, et al.
Published: (2019-11-01)

Cannabinoid type-1 receptor signaling in dopaminergic Engrailed-1 expressing neurons modulates motivation and depressive-like behavior
by: Sarah Baddenhausen, et al.
Published: (2024-04-01)

The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?
by: Shirin Sadighparvar, et al.
Published: (2019-07-01)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Dopaminergic Epistases in Schizophrenia
by: Adela Bosun, et al.
Published: (2024-10-01)

Downregulation of Ambra1 by altered DNA methylation exacerbates dopaminergic neuron damage in a fenpropathrin-induced Parkinson-like mouse model
by: Songzhe He, et al.
Published: (2024-02-01)

Altered Development of Mesencephalic Dopaminergic Neurons in SIDS: New Insights into Understanding Sudden Infant Death Pathogenesis
by: Anna Maria Lavezzi
Published: (2021-10-01)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)

Aromatic-Turmerone Analogs Protect Dopaminergic Neurons in Midbrain Slice Cultures through Their Neuroprotective Activities
by: Yuria Hori, et al.
Published: (2021-05-01)

Role of peripheral dopaminergic system in the pathogenesis of experimental colitis in rats
by: A. I. Prysiazhniuk, et al.
Published: (2017-08-01)

THE ORGANIZATION OF NON-DOPAMINERGIC NIGRAL PROJECTIONS TO THE THALAMIC NUCLEUS OF THE RAT
by: Mehdizadeh M, et al.
Published: (2001-01-01)

Serotonin syndrome in a patient with chronic pain taking analgesic drugs mistaken for psychogenic nonepileptic seizure: a case report
by: Mathieu Boudier-Revéret, et al.
Published: (2021-10-01)

Circulating prolactin levels and the effect of dopaminergic agonists in systemic lupus erythematosus: a systematic review and meta-analysis
by: Álida Alves dos Santos, et al.
Published: (2024-12-01)

Endogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation
by: Julieta Mendes-Oliveira, et al.
Published: (2023-12-01)

Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy
by: La Dong, et al.
Published: (2025-03-01)

Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Appotosis and Glial Cell-derived Neurotrophic Factor: in Vivo and in Vitro
by: Qian Xu, et al.
Published: (2016-12-01)

Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain
by: Tatiana V. Tarasova, et al.
Published: (2018-05-01)